NOX — Noxopharm Share News
0.000.00%
- AU$26.30m
- AU$30.46m
- AU$2.83m
Australia's Noxopharm rises as co gets tax refund
Brief: Noxopharm Receives A$5.865 Mln R & D Tax Rebate Under Australian Govt's Research And Development Tax Incentive Scheme During FY21
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:27:23
Australia Stock Exchange release from NOXOPHARM : Noxopharm Receives A$5.865M R & D Tax Rebate
Australia's Noxopharm hits one-month high after CEO appointment
Brief: Noxopharm Appoints Gisela Mautner As Chief Executive Officer
Australia Stock Exchange release from NOXOPHARM : Noxopharm Announces Leadership Transition
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:02:54
Australia Stock Exchange release from NOXOPHARM : Noxopharm DARRT-2 Cancer Trial Update
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 10:03:58
Australia Stock Exchange release from NOXOPHARM : Notification of cessation of securities - NOX
Australia Stock Exchange release from NOXOPHARM : Change of Director's Interest Notice - GK
Australia Stock Exchange release from NOXOPHARM : Noxopharm Annual General Meeting Results
Brief: Noxopharm Ltd Says Unit Entered Into A Licence Agreement With Hudson Institute Of Medical Research
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:41:26
Australia Stock Exchange release from NOXOPHARM : Licencing Deal Expands Noxopharm Drug Opportunities
Australia Stock Exchange release from NOXOPHARM : Noxopharm 2021 AGM Corporate Presentation
Australia Stock Exchange release from NOXOPHARM : Noxopharm 2021 AGM Chairmans Address
Brief: Noxopharm Retracts Announcement On Award Of A$8.8 Mln Grant